ROTHBLATT MARTINE A sold UTHR
April 2, 2026 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 40 shares of United Therapeutics Corporation at $559.98 per share, a transaction worth $22.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
40
Price
$559.98
Total value
$22.4K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 2, 2026
Filing dateApril 6, 2026
Shares owned after46,253
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.